24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Corporate
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
89Bio
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
16:36
Founders keep asking me if this is a bubble. That's the wrong question.
16:31
Ohio office building bought for $17 million sells for just $2 million, deepening concerns over Israeli real estate investment firm Realco
16:18
Airlines ramp up Israel flights ahead of summer travel rush
14:00
Travel fintech Faye raises $50 million Series C at estimated $500 million valuation
More stories
Buzz
Most popular
Daily
Weekly
1
Billionaire Beny Steinmetz challenges $1.4 million tax demand over $9 million Israeli home sale
2
Salesforce veterans raise $20 million pre-Seed from Marc Benioff and Michael Dell to tackle AI’s enterprise bottleneck
3
Wix's Base44 bet comes at a price as losses widen to $76.4 million
4
Monday seeks to double CEO pay weeks after announcing 620 layoffs
5
25-year-old AI investor’s $16 billion bet hits a brutal reality check
More news
89Bio
3 stories about 89Bio
Roche strikes $3.5 billion deal for U.S.-Israeli biotech 89bio
18.09.25
|
CTech
Founded in 2018 from Teva’s pipeline, the biotech firm is set to become a centerpiece in Roche’s obesity strategy.
Teva-Linked Biotech Company 89Bio Files for Nasdaq IPO
15.10.19
|
CTech
Israel and San Francisco-based 89Bio raised a $60 million series A in October 2018
Former Teva Executives Raise $60 Million for Metabolic Disorders Venture
28.10.18
|
Lilach Baumer
The company’s pipeline of biologic and small molecule drug candidates was acquired from Teva